2 domains / 4 areas / 2 specializations
Canadian Drug Agency (CDA-AMC)
Data updated
Canadian public HTA and reimbursement review body supporting evidence appraisal for access decisions.
Reimbursement & Market Access Snapshot
Health EconomistsService Model
HTA / Value Assessment Body
Jurisdiction
National
Coverage
1 country
Last Verified
Apr 8, 2026
Focus Areas
Evidence Requirements
Market Access Notes
CDA-AMC recommendations and evidence appraisals support reimbursement decision-making across Canadian public drug plans, including esketamine evaluations.
Verification
Verified
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement Status
Active
Public Sector Governance Snapshot
Health Technology Assessment AgenciesAuthority Type
Health Technology Assessment Agency
Jurisdiction
National
Coverage
1 country
Framework Status
Active
Function Areas
Governance Notes
Wave 1 governance profile seeded for Canadian Drug Agency (CDA-AMC).
Verification
Verified
Psychedelic Engagement
Psychedelic-Adjacent Focus
Last Verified
Apr 13, 2026
Quick Facts
- Website
- Visit